Available online 17 May 2022, 151176
AbstractHeart transplantation (HTx) has a storied past, with origins dating back to the early twentieth century and the first pediatric orthotopic heart transplant performed in 1967 on a neonate with Ebstein abnormality. Today, approximately 500 pediatric HTx are performed annually, with survival times now measured in decades rather than days or weeks. In large part, advances in immunosuppression, critical care, dedicated transplant teams and mechanical circulatory support have paved the way for improvements in waitlist mortality and post-transplant survival, with future directions including the development of intracorporeal ventricular assist devices (VADs) for small children, expanding/standardizing donor criteria, and xenotransplantation.
Key WordsCardiomyopathy
Congenital heart disease
Heart failure
Mechanical circulatory support
Pediatric heart transplantation
Ventricular assist device
View full text© 2022 Elsevier Inc. All rights reserved.
留言 (0)